In breast cancer, increased COX-2 expression signals poor prognosis, and is associated with high tumor cell proliferation rates, high histological grade, ductal carcinoma in situ, elevated p53 expression, HER-2 amplification, and axillary node involvement [86]. Here, PTGS2 is linked to breast cancer.